Actively Recruiting
Lifetime Endurance Exercise to Prevent Coronary Artery Disease
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-03
1800
Participants Needed
3
Research Sites
362 weeks
Total Duration
On this page
Sponsors
U
Universitaire Ziekenhuizen KU Leuven
Lead Sponsor
U
University Hospital, Antwerp
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of the Master@Heart Trial is to investigate whether lifelong endurance exercise reduces the incidence of non-calcified plaques (both mixed and soft plaques) as compared to late-onset endurance exercise and a non-athletic lifestyle.
CONDITIONS
Official Title
Lifetime Endurance Exercise to Prevent Coronary Artery Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male participants aged 45 to 70 years
- Lifelong endurance athletes who started endurance sports before age 30 and compete at regional, national, or international levels
- Lifelong athletes involved in triathlon, cycling, distance running (1500 meters and longer), or rowing
- Lifelong athletes training more than 10 hours weekly for cyclists and triathletes, or more than 6 hours weekly for runners and rowers
- Late-onset endurance athletes who started endurance sports after age 30 at least 6 months ago and compete at regional, national, or international levels
- Late-onset athletes involved in triathlon, cycling, distance running (1500 meters and longer), or rowing
- Late-onset athletes training more than 10 hours weekly for cyclists and triathletes, or more than 6 hours weekly for runners and rowers
- Healthy non-athletes with less than 3 hours per week of regular sports practice
- Non-athletes allowed to participate in low dynamic sports (e.g., billiards, darts, bowling) more than 3 hours per week
- Non-athletes recruited from outpatient clinics for work-related medical check-ups, university alumni, or multisports organizations
You will not qualify if you...
- History of smoking more than 5 pack years
- History of diabetes
- Prior diagnosis of any cardiopulmonary disorder
- Current medical treatment for arterial hypertension or hypercholesterolemia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University Hospital, Antwerpen
Edegem, Belgium, 2650
Actively Recruiting
2
Jessa Hospital
Hasselt, Belgium, 3500
Actively Recruiting
3
UZLeuven
Leuven, Belgium, 3000
Actively Recruiting
Research Team
G
Guido Claessen, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here